论文部分内容阅读
目的探讨脑血管病后继发癫痫患者采用拉莫三嗪与卡马西平治疗的疗效和安全性。方法选取2013年12月至2015年12月杞县人民医院收治的脑血管病后继发癫痫患者114例,随机分为两组,各57例。对照组给予卡马西平治疗,观察组给予拉莫三嗪治疗,对比两组治疗有效率和不良反应发生率。结果观察组治疗有效率高于对照组,差异显著(P<0.05);观察组总不良反应发生率低于对照组,差异显著(P<0.05)。结论脑血管病后继发癫痫患者采用拉莫三嗪治疗效果优于卡马西平治疗,可明显提高疗效,安全性高。
Objective To investigate the efficacy and safety of lamotrigine and carbamazepine in patients with secondary epilepsy after cerebrovascular disease. Methods A total of 114 patients with secondary epilepsy after cerebrovascular disease admitted to Qixian People’s Hospital from December 2013 to December 2015 were randomly divided into two groups (57 in each group). The control group was given carbamazepine treatment, and the observation group was treated with lamotrigine. The treatment efficiency and incidence of adverse reactions in the two groups were compared. Results The effective rate of observation group was higher than that of control group (P <0.05). The incidence of adverse reactions in observation group was lower than that of control group (P <0.05). Conclusions Lamotrigine is superior to carbamazepine in patients with secondary epilepsy after cerebrovascular disease, which can obviously improve the curative effect and safety.